R. I. Freudenthal
- Pharmacology top 5%
- Cellular and Molecular Neuroscience
- Pharmacology top 10%
- Toxicology top 5%
- Pediatrics, Perinatology and Child Health
- Co-authors
- Monroe E. WallRoni RosenfeldJoseph T. MartinH. Dix ChristensenDolores R. BrineColin G. PittF. Ivy CarrollCharles L. Litterst
- Topics
- Pharmacogenetics and Drug Metabolism (6 papers)Carcinogens and Genotoxicity Assessment (3 papers)Metabolism and Genetic Disorders (3 papers)
- Cited by
- ToxicologyPharmacology
- Partner nations
- United States
In The Last Decade
R. I. Freudenthal
21 papers receiving 320 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 191
- Cellular and Molecular Neuroscience 98
- Pharmacology 71
- Toxicology 54
- Pediatrics, Perinatology and Child Health 52
Countries citing papers authored by R. I. Freudenthal
This map shows the geographic impact of R. I. Freudenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. I. Freudenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. I. Freudenthal more than expected).
Fields of papers citing papers by R. I. Freudenthal
This network shows the impact of papers produced by R. I. Freudenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. I. Freudenthal. The network helps show where R. I. Freudenthal may publish in the future.
Co-authorship network of co-authors of R. I. Freudenthal
This figure shows the co-authorship network connecting the top 25 collaborators of R. I. Freudenthal. A scholar is included among the top collaborators of R. I. Freudenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. I. Freudenthal. R. I. Freudenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 14 | |
| 7 | Dietary subacute toxicity of ethylene thiourea in the laboratory rat. | 8 |
| 8 | Comparison of the drug metabolizing enzymes in the liver and kidneys from homozygous nude swiss, heterozygous normal swiss, homozygous normal swiss and dba/2 mice. | 2 |
| 9 | 41 | |
| 10 | 13 | |
| 11 | Carcinogenesis: a comprehensive survey. Volume I. Polynuclear aromatic hydrocarbons: chemistry, metabolism, and carcinogenesis | 6 |
| 12 | 8 | |
| 13 | 24 | |
| 14 | 3 | |
| 15 | 5 | |
| 16 | 48 | |
| 17 | 6 | |
| 18 | 6 | |
| 19 | 9 | |
| 20 | 138 |
About R. I. Freudenthal
R. I. Freudenthal is a scholar working on Pharmacology, Clinical Biochemistry and Pharmaceutical Science, having authored 21 papers that have together received 354 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Toxicology (54 citations), Pharmacology (191 citations) and Pharmacology (71 citations). R. I. Freudenthal has collaborated with scholars based in United States. Frequent co-authors include Monroe E. Wall, Roni Rosenfeld, Joseph T. Martin, H. Dix Christensen, Dolores R. Brine, Colin G. Pitt, F. Ivy Carroll, Charles L. Litterst, Edward G. Mimnaugh and Joseph V. Martin. Their work appears in journals such as Science, Analytical Biochemistry and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.